What are the potential risks and contraindications associated with hyperbaric oxygen therapy?

Dangers of Hyperbaric Oxygen Therapy

Hyperbaric oxygen therapy is generally safe when properly administered, but carries specific risks including oxygen toxicity (seizures, pulmonary damage), middle ear barotrauma, and visual disturbances, with the most serious complication being CNS oxygen toxicity manifesting as seizures.

Primary Risks and Complications

Oxygen Toxicity (Most Serious)

Acute CNS Toxicity (Paul Bert Effect)

• Occurs from brief exposure to very high oxygen pressures during HBOT
• Clinical manifestations: nausea, dizziness, anxiety, tinnitus, tunnel vision, muscle twitching (especially facial and hand muscles), and generalized tonic-clonic seizures in severe cases 1
• Risk factors that worsen toxicity: elevated CO₂, physical stress, cold, and fatigue 1
• Important caveat: These seizures are typically self-limiting, do not predispose to chronic epilepsy, and are regarded as benign—rarely requiring specific anticonvulsant therapy 1

Chronic Pulmonary Toxicity (Smith Effect)

• Follows prolonged exposure to moderately elevated oxygen (as low as 0.5 ATA)
• Symptoms: cough, pleuritic chest pain, substernal heaviness, dyspnea, eventually pulmonary edema 1
• Pathophysiology: oxidative stress damages alveolar epithelium, disrupts surfactant, provokes inflammation, increases capillary leak 1
• Without intervention, can progress to atelectasis and fibrosis 1

Barotrauma

Middle Ear Barotrauma (Most Common Complication)

• Occurs in 9.2% of patients but only 0.04% of individual sessions 2
• Overall per-session adverse event incidence: 0.72% 2
• Higher risk groups: females and children under 16 years 2
• Can be prevented or minimized by teaching autoinflation techniques or inserting tympanostomy tubes 3

Visual Disturbances

• Progressive myopia is the most common visual complication 3
• Usually transient and reversible after stopping HBOT sessions 3
• Other reported effects: narrowed field of vision, cataracts 1
• Special neonatal risk: prolonged exposure >40% oxygen may lead to retrolental fibroplasia (retinopathy of prematurity) 1

Cardiovascular Complications

Heart Failure Exacerbation

• HBOT increases afterload (vasoconstriction) and decreases cardiac output 4
• In a retrospective study of 23 HF patients receiving HBOT, 2 patients (8.7%) developed HF exacerbations 4
• One patient with HFrEF (LVEF 24%) developed pulmonary edema after 4 treatments (had voluntarily held diuretics) 4
• Another with HFpEF (LVEF 64%) developed dyspnea requiring hospitalization after 6 sessions 4
• Key point: Patients with HF can receive HBOT safely after optimization of HF therapy and fluid restriction, but require ongoing surveillance 4

Other Complications (Less Common)

• Claustrophobia and anxiety: frequent complaint requiring reassurance, coaching, sometimes sedation 3
• Hypoglycemia, dizziness, dyspnea, chest pain: occur in 0.5-1.5% of patients 2
• Pulmonary edema: rare reports during emergency treatment 4

Risk Mitigation Strategies

Preventive Protocols

For CNS Toxicity:

• Use prophylactic anticonvulsants in high-risk patients 1
• Schedule "air breaks" (intervals of ambient air breathing) during sessions—can reduce seizure risk by up to tenfold 1
• Limit chamber pressure appropriately 1

For Barotrauma:

• Pre-HBOT therapy evaluations essential 2
• Teach autoinflation techniques 3
• Consider tympanostomy tubes in high-risk patients 3

For All Complications:

• Strict operational protocols with in-chamber monitoring 2
• Use lowest effective FiO₂ in at-risk populations (ARDS patients, preterm infants) 1

Specific Contraindications and High-Risk Populations

Relative Contraindications

• Hemodynamic or respiratory instability in acute phase (especially severe burn patients) 5
• Heart failure with reduced ejection fraction (requires optimization before treatment) 4
• Severe arterial disease (associated with negative outcomes) 6

Vulnerable Populations Requiring Extra Caution

• Premature infants: increased risk of retinopathy of prematurity and bronchopulmonary dysplasia 1
• Pregnant women: while HBOT is indicated for CO poisoning regardless of symptoms, requires careful monitoring 1
• Patients with coronary disease 1
• Pediatric patients 1

Clinical Context: When Benefits Outweigh Risks

Despite these risks, HBOT remains "one of the safest medical treatments available today" when strict protocols are followed 2. The overall adverse event rate of 17.4% of patients (0.72% per session) is low, with most complications being mild and transient 2, 6.

Critical decision-making factors:

• Severity of underlying condition requiring HBOT
• Patient stability and comorbidities
• Availability of specialized team and equipment 5
• Timing considerations (e.g., <6 hours for CO poisoning) 1
• Transport risks versus treatment benefits 1

The indication for HBOT should be evaluated case-by-case, balancing the potential for serious complications against the therapeutic benefit for the specific indication 5.